A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2330

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 SARS-CoV-2 Infection

Interventions

DRUG: ibuzatrelvir
DRUG: placebo

Sponsor

Pfizer